Prof Pamela Russell AM
"Funding for early-career researchers is absolutely critical in order to allow them to start a career in science or in research, but in particular to help the patients who have cancer."
Imaging of Prostate cancer and studies of Bone Metastases
Former Head of Biomedical Imaging and Prostate Cancer Models. Now retired.
Also served on the Medical Grants Advisory Committee for Cure Cancer for many years.
Professor Pamela Russel has received grants from Cure Cancer (then the Leo & Jenny Foundation) totaling $175,000 across 1988, 1990, 1991, 1993, 1994, 1996.
She is internationally recognised for her work on bladder and prostate cancer. Career highlights include production of monoclonal antibodies against cancer and targeted nanoparticle imaging to improve diagnosis and staging of prostate cancer.
Pamela has written over 200 papers for international journals, numerous books, chapters and conference papers, and holds 2 international and several provisional patents. She collaborates widely within Australia and overseas, and to date has raised over $37 million in competitive grants and industry support, mentored 31 post-doctoral scholars, and helped to run 4 international conferences.
Her Impact on Australian Research
In addition to her ground-breaking studies, Pamela has helped to establish organisations which have had a profound impact on the oncology world, including the Prostate Cancer Foundation of Australia, the Australasian Genitourinary Oncology Group and the Australasian Urological and Prostate Cancer Clinical Trials Group. She is a member of the Australian Prostate Cancer Collaboration and has been involved with the Global Action Plan for Movember, bringing together expert clinicians and researchers around the world to make breakthroughs for treating advanced prostate cancer.
Cure Cancer had funded and is currently funding researchers at the Australian Prostate Cancer Research Centre – Queensland. (Dr Jenni Gunter in 2013, Dr Brett Hollier in 2016 and A/Prof Jyotsna Batra a 2017 grant recipient , supported by The Can Too Foundation). The success of this unit has been strongly influenced by Pam’s presence.
For her incredible work, Pam was made a member of the Order of Australia in 2005, and received an Honorary Life Membership of the Prostate Cancer Foundation of Australia in 2006, an Honorary Life Membership of the Australasian Gene Therapy Society in 2009, the inaugural award for Prostate Cancer Researcher of the Year in 2010, and made Fellow of the Australian Academy of Health and Medical Sciences in 2015.
We need your help
Donate to fund future researchers like Pamela and let’s make this the last generation to die from cancer.